ストックスクリーナーアプリを入手
10.84
1.31%
0.14
前日終値:
$10.70
開ける：
$10.87
24時間の取引高:
94,515
Relative Volume:
0.56
時価総額：
$371.32M
収益：
$7,000
当期純損益:
$-38.96M
株価収益率:
-11.66
EPS:
-0.9296
ネットキャッシュフロー:
$-18.34M
1週間 パフォーマンス:
-7.19%
1か月 パフォーマンス:
-1.45%
6か月 パフォーマンス:
-21.45%
1年 パフォーマンス:
-26.11%
1日の値動き範囲:
$10.66
$11.13
1週間の範囲:
$10.50
$11.85
52週間の値動き範囲:
$9.85
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
Compare BNTC vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
10.84 | 366.53M | 7,000 | -38.96M | -18.34M | -0.9296 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-07 | 開始されました | TD Cowen | Buy |
| 2024-12-16 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-13 | 開始されました | Robert W. Baird | Outperform |
| 2024-10-16 | 開始されました | Oppenheimer | Outperform |
| 2024-09-12 | 開始されました | Guggenheim | Buy |
| 2024-07-22 | 開始されました | Leerink Partners | Outperform |
| 2024-06-13 | 開始されました | Piper Sandler | Overweight |
| 2020-10-05 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-02-26 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-12-31 | 繰り返されました | Maxim Group | Buy |
| 2015-09-16 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Benitec Biopharma Inc (BNTC) 最新ニュース
Benitec Biopharma (NASDAQ:BNTC) Shares Pass Below Fifty Day Moving Average – Here’s What Happened - Defense World
Benitec Biopharma Limited (NASDAQ:BNTC) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
(BNTC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Market Moves: Is Benitec Biopharma Inc forming a double bottom2026 Closing Moves & Verified Short-Term Plans - baoquankhu1.vn
BNTC SEC FilingsBenitec Biopharm 10-K, 10-Q, 8-K Forms - Stock Titan
Benitec Biopharma (NASDAQ: BNTC) FY 2025 loss widens to $37.9M - Stock Titan
Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above 50 Day Moving AverageWhat's Next? - MarketBeat
Risk Recap: What is the dividend yield of Benitec Biopharma Inc2026 Setups & Low Drawdown Trading Strategies - baoquankhu1.vn
Portfolio Recap: Is Benitec Biopharma Inc stock a good dividend stockDollar Strength & High Accuracy Swing Trade Signals - baoquankhu1.vn
Jerel A. Banks, MD, PhD, on Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia - CGTLive®
Surprises Report: Can Benitec Biopharma Inc maintain its current growth rate2026 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn
(BNTC) Risk Channels and Responsive Allocation - Stock Traders Daily
Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development for - The Manila Times
Benitec Biopharma to Host Industry Forum Breakfast Event at - GlobeNewswire
Benitec Biopharma (NASDAQ:BNTC) Receives Buy Rating from HC Wainwright - Defense World
Breakfast talk to show OPMD swallowing gains from gene therapy BB-301 - Stock Titan
Benitec Biopharma Inc. (BNTC) Competitors - Meyka
Cowen Reiterates Buy on Benitec Biopharma (BNTC) March 2026 - Meyka
Benitec Biopharma : Corporate Presentation, March 2026 - marketscreener.com
Benitec BioPharma stock maintains Buy rating on positive trial data By Investing.com - Investing.com South Africa
Benitec BioPharma stock maintains Buy rating on positive trial data - Investing.com
BNTC: HC Wainwright & Co. Reiterates Buy Rating on Benitec Bioph - GuruFocus
Benitec reports interim results from gene therapy trial - Investing.com Nigeria
Benitec Biopharma (BNTC) Reports Encouraging Interim Results fro - GuruFocus
Benitec Biopharma Announces Positive Interim Phase 1b/2a - GlobeNewswire
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference - Bitget
Benitec Biopharma Stock Pre-Market (+7.1%): Analyst Raises EPS Forecasts - Trefis
Sentiment Recap: What is the Moat Score of Benitec Biopharma IncJuly 2025 Outlook & Stock Timing and Entry Methods - baoquankhu1.vn
New Highs: How liquid is Benitec Biopharma Inc stockJuly 2025 Momentum & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
HC Wainwright Expects Higher Earnings for Benitec Biopharma - Defense World
HC Wainwright Issues Optimistic Forecast for BNTC Earnings - MarketBeat
Levels Update: Is Benitec Biopharma Inc exposed to political riskTreasury Yields & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Research Analysts Offer Predictions for BNTC Q1 Earnings - Defense World
Analysts Issue Forecasts for BNTC Q1 Earnings - MarketBeat
(BNTC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Benitec Biopharma Limited (NASDAQ:BNTC) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Benitec Biopharma Inc. (BNTC) - DirectorsTalk Interviews
Benitec BioPharma stock rating maintained on gene therapy data - Investing.com Nigeria
Benitec BioPharma stock rating maintained on gene therapy data By Investing.com - Investing.com Australia
Benitec Biopharma Announces Acceptance of Late- Breaking - GlobeNewswire
Durable BB-301 responses in muscular dystrophy to be detailed at MDA 2026 - Stock Titan
Benitec Biopharma (BNTC) Stock Analysis: Unpacking A 125% Potential Upside - DirectorsTalk Interviews
Liquidity Mapping Around (BNTC) Price Events - Stock Traders Daily
What insider trading reveals about Benitec Biopharma Inc. stockJuly 2025 Opening Moves & Verified Swing Trading Watchlists - mfd.ru
Growth Value: What insider trading reveals about Benitec Biopharma Inc. stockMarket Trend Summary & Smart Money Movement Alerts - mfd.ru
Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation - Yahoo Finance
Hedge funds owners may consider drastic measures as Benitec Biopharma Inc.'s (NASDAQ:BNTC) recent US$60m drop adds to long-term losses - simplywall.st
Wall Street Zen Downgrades Benitec Biopharma (NASDAQ:BNTC) to Sell - MarketBeat
BNTC PE Ratio & Valuation, Is BNTC Overvalued - Intellectia AI
Benitec Biopharma (NASDAQ:BNTC) Announces Quarterly Earnings Results - MarketBeat
Benitec Biopharma Inc. (BNTC) Investor Outlook: Analyst Ratings Signal a Promising 104.58% Upside Potential - DirectorsTalk Interviews
Benitec Biopharma Inc (BNTC) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):